GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the inhibited form of the redox-sensitive sufe- like sulfur acceptor csde from escherichia COLI at 2.40 ångström resolution

Analyse Crystal structure of the inhibited form of the redox-sensitive sufe- like… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5NQ6
Type
protein
Length
283 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Sulfur acceptor protein csde
UniProt
P0AGF2
Ligands
SO4
Pockets
2 · best druggability 0.56

Structure

x-ray diffraction · 2 distinct chains · 49% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASulfur acceptor protein csdeprotein14148% helix, 16% strandP0AGF2
BSulfur acceptor protein csdeprotein14249% helix, 16% strandP0AGF2

Ligands and binding sites

  • SO4 · Sulfate ion · ion · chains B
  • GOL · Glycerol · additive · 5 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12230.560.7931GOL
2680.330.7617empty

Interfaces

1 interface between chains.

  • A–B · 445 Ų buried · 6 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 5NQ6 · Crystal structure of the inhibited form of the redox-sensitive SufE-like sulfur acceptor… · the same entry in another collection · chain A against A, TM-score 1.00
  • P0AGF2 · AlphaFold monomer V2.0 prediction for sulfur acceptor protein csde (P0AGF2) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.